From a clinical perspective, the elevated FSH levels in menorrhagic women might suggest a potential endocrine disruption, prompting clinicians to explore hormonal treatments or further investigate ovarian function in these patients.33 The corroboration of the current findings with studies from different populations (like the Egyptian study)24 reinforces the idea that menorrhagia might be associated with hormonal imbalances across diverse groups, which could have implications for global health approaches to managing menstrual disorders. This evidence concerns the gene BRD2 and Menstrual disorder.